The FDAs Pharmacy Compounding Advisory Committee (PCAC) is scheduled to formally review BPC-157 for inclusion on the 503A Bulks List on July 23, 2026
Predicted Pricing and Insurance Coverage Expected Monthly Costs Both will be expensive
Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B, Pediatric Oncology Group 9048, Childrens Cancer Group 8891 (2004) Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup StudyPediatric Oncology Group 9048 and Childrens Cancer Group 8891
After that, they need a shot every month
Detect fraud, misuse, diversion, security incidents, and prohibited activity